Abstract
To evaluate if the Human epidermal growth factor receptor 2 (HER-2) expression levels may be used as potential prognostic marker in high grade T1 blad- der cancer (T1G3) METHODS: Specimens from transurethral resection of bladder tumour (TURBT) of 103 patients with high-grade T1 bladder cancer were collected. This pathologic database was reviewed. Four-year follow-up data were matched with pathologic data. Eighty-three patients entered the study. HER-2 staining was performed. Patients were grouped for HER-2 status. Statistical analysis included Kaplan Meier survival analysis and Log-rank test.
| Original language | English |
|---|---|
| Pages (from-to) | 73-77 |
| Number of pages | 5 |
| Journal | Archivio Italiano di Urologia Andrologia |
| Volume | 85 |
| DOIs | |
| Publication status | Published - 2013 |
Keywords
- Adult
- Aged
- Aged, 80 and over
- Carcinoma, Transitional Cell
- Cystectomy
- Disease-Free Survival
- Female
- Follow-Up Studies
- Humans
- Immunohistochemistry
- Kaplan-Meier Estimate
- Male
- Middle Aged
- Neoplasm Grading
- Neoplasm Proteins
- Neoplasm Staging
- Prognosis
- Receptor, ErbB-2
- Tumor Markers, Biological
- Urinary Bladder Neoplasms
